Hyperfine (HYPR) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Hyperfine (HYPR) has outperformed Outset Medical (OM) over the past year, losing 50.6% versus a loss of 72.0%. Over five years, HYPR leads with a -91.5% price change compared with -99.4% for OM. Hyperfine is the larger company by market cap ($90.0 million vs $79.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HYPR | OM |
|---|---|---|
| Share price | $0.849 | $4.21 |
| Market cap | $90.04M | $79.14M |
| 1-day change | -2.41% | +1.69% |
| YTD return | -13.28% | +13.48% |
| 1-year return | -50.64% | -71.95% |
| 5-year return | -91.46% | -99.42% |
| EPS (TTM) | $-0.37 | $-4.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.22 | $16.16 |
| 52-week low | $0.754 | $2.84 |
| Distance from 52-week high | -61.76% | -73.95% |
| Average volume | 642.03K | 160.91K |
| Shares outstanding | 90.99M | 18.80M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HYPR has outperformed OM by 21.3 percentage points over the past year.
HYPR vs OM FAQ
Which is bigger, Hyperfine or Outset Medical?
Hyperfine (HYPR) is larger, with a market capitalization of $90.04M compared with $79.14M for Outset Medical (OM).
Which stock has performed better over the past year, HYPR or OM?
HYPR returned -50.64% over the past 12 months, compared with -71.95% for OM (price return, excluding dividends). Past performance does not predict future results.
Are Hyperfine and Outset Medical in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.